Suchergebnisse - "Kow, Chia Siang"

PubPharm (300)

21

Is molnupiravir a wise investment? Reassessing COVID-19 treatment strategies

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: J Antimicrob Chemother. 2023 Sep 5;78(9):2131-2139. - PMID 37437106

22

Therapeutic-dose heparin in preventing COVID-19-associated acute kidney injury : What about bleeding risk?

enthalten in: Research and practice in thrombosis and haemostasis | 2023

von Kow, C. | Thiruchelvam, K.

23

Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19

enthalten in: The Annals of pharmacotherapy | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Ann Pharmacother. 2023 Jul;57(7):769-775. - PMID 36314277

24

Embracing Imatinib : a novel approach to safeguarding the endothelial barrier in patients with COVID-19

enthalten in: Angiogenesis | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Angiogenesis. 2023 Apr 27;:null. - PMID 37103631

25

Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes

enthalten in: Inflammopharmacology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S. | +1

26

Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support : a systematic review and meta-analysis of randomized trials

enthalten in: Inflammopharmacology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

27

Killing two birds with one stone : The potential of iron supplementation in Chinese HFrEF patients

enthalten in: Journal of the Chinese Medical Association : JCMA | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

28

RAAS inhibitors in COVID-19 : They are not all the same!

enthalten in: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Rev Port Cardiol. 2023 Apr;42(4):373-383. - PMID 36893838

29

Favipiravir and hyperuricemia in patients with COVID-19-suggestions for future studies

enthalten in: The Lancet regional health. Southeast Asia | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

30

The impact of preadmission/prediagnosis use of GLP-1 receptor agonists on COVID-19 mortality in patients with diabetes : A systematic review and meta-analysis

enthalten in: Health science reports | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.